共 143 条
[11]
Kanis JA(2002)The estimation of a preference-based measure of health from the SF-36 J Health Econ 21 271-292
[12]
Johnell O(2004)To what extent do people prefer health states with higher values? A note on evidence from the EQ-5D valuation set Health Econ 13 733-737
[13]
Jonsson B(2009)An updated systematic review of health state utility values for osteoporosis related conditions Osteoporos Int 20 853-868
[14]
Jonsson L(2012)The effect of risedronate (17.5 mg/week) treatment on quality of life in Japanese women with osteoporosis: a prospective observational study J Bone Miner Metab 30 715-721
[15]
Black D(2013)The International Costs and Utilities Related to Osteoporotic Fractures Study (ICUROS)—quality of life during the first 4 months after fracture Osteoporos Int 24 811-823
[16]
Tosteson ANA(2004)A comparison of the EQ-5D and SF-6D across seven patient groups Health Econ 13 873-884
[17]
Melton LJ(2002)A systematic review of health state utility values for osteoporosis-related conditions Osteoporos Int 13 768-776
[18]
Dawson-Hughes B(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement PLoS Med 6 e1000097-186
[19]
Baim S(1997)Does blinding of readers affect the results of meta-analyses? Lancet 350 185-1558
[20]
Favus MJ(2002)Quantifying heterogeneity in a meta-analysis Stat Med 21 1539-560